Assessment of Lead (Pb) Toxicity in Juvenile Nile Tilapia, Oreochromis niloticus -Growth, Behaviour, Erythrocytes Abnormalities, and Histological Alterations in Vital Organs.
Tayeeba Ferdous MahiGourab ChowdhuryMohammad Amzad HossainAsim Kumar BaishnabPetra SchneiderMohammed Mahbub IqbalPublished in: Toxics (2022)
Lead (Pb) is one of the toxins responsible for the deterioration of ecological health in aquatic environments. The present study investigated the effects of Pb(NO 3 ) 2 toxicity on growth, blood cell morphology, and the histopathology of gills, liver, and intestine of juvenile Nile tilapia, Oreochromis niloticus . A 30-day long aquarium trial was conducted by assigning three treatment groups T 1 5.20 mg L -1 , T 2 10.40 mg L -1 , and T 3 20.80 mg L -1 , and a control 0 mg L -1 following the 96 h LC 50 of 51.96 mg L -1 from acute toxicity test. Overall growth performance significantly declined in all the Pb(NO 3 ) 2 treated groups and the highest mortality was recorded in T 3 . Behavioural abnormalities were intense in all the treatment groups compared to the control. Hepatosomatic index (HSI) values were reported as higher in treatment groups. Reduced nucleus diameter and nuclei size in erythrocytes were reported for T 2 and T 3 groups. Dose-dependent histological alterations were visible in the gills, liver, and intestine of all the Pb(NO 3 ) 2 treated groups. The width of the intestinal villi was highly extended in T 3 showing signs of severe histological alterations. In conclusion, Pb toxicity causes a negative effect on growth performance, erythrocyte morphology, and affected the vital organs histomorphology of juvenile O. niloticus.
Keyphrases
- heavy metals
- oxidative stress
- healthcare
- risk assessment
- aqueous solution
- public health
- randomized controlled trial
- type diabetes
- mental health
- coronary artery disease
- cardiovascular events
- replacement therapy
- study protocol
- high resolution
- drug induced
- newly diagnosed
- human health
- hepatitis b virus
- mechanical ventilation
- optical coherence tomography
- phase ii
- phase iii